Need Help?

Nimblegen

The Cardiogenics re-sequencing study will consist of three parts: Eight pools of 25 individuals will be sequenced using a Nimblegen hybrid-capture solution specific to miRNA sequences, 80 pools of 25 individuals will be sequenced using a custom Agilent SureSelect array covering genes associated with coronary artery disease (CAD) and myocardial infarction (MI), 10 individuals from families with a history of CAD/MI will be exome sequenced using the Sanger exome array. The experiment will use the early onset patients from the German MI cohort and the UK BHF CAD/MI cohort both of which have strong family history. For controls we will consider individuals from the UKBS and KORA cohorts.

Request Access

Wellcome Trust Sanger Institute Data Sharing Policy

https://www.sanger.ac.uk/datasharing/

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
Resequencing

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00000079075 bam 6.8 GB
EGAF00000079076 bam 8.3 GB
EGAF00000079077 bam 7.0 GB
EGAF00000079078 bam 7.7 GB
EGAF00000079079 bam 7.9 GB
EGAF00000079080 bam 7.9 GB
EGAF00000079081 bam 11.4 GB
EGAF00000079082 bam 8.3 GB
8 Files (65.2 GB)